The first patient has been enrolled in the RE-SPECT ESUS study, which will investigate the safety of dabigatran etexilate for the prevention of recurrent embolic stroke of undetermined source, according to a press release from Boehringer Ingelheim.
For patients suffering from acute ischemic stroke caused by a proximal intracranial occlusion of the anterior circulation, intraarterial treatment administered within six hours after the stroke’s onset may be effective and safe.
In asymptomatic patients with moderate to severe aortic regurgitation (AR) or mitral regurgitation (MR), does regurgitant volume index correlate with left ventricular (LV) dysfunction?
Sandhu and colleagues conducted the study to compare national influenza activity from the CDC vs. monthly admissions for acute aortic dissection and their institution from 2001 to 2013.
Данный сайт и вся информация на нём предназначена для медицинских работников.
Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.